Schedule 13G ownership disclosure

Eton Pharmaceuticals Inc

Security class unavailable · CUSIP: 29772L108

Event date: 2020-05-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.2700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-20-009823
Form type
SC 13G/A
Filer
HARROW, INC.
CIK
CIK 1360214
Filed
May 26, 2020
Reporting period
May 14, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub